> Canada's Aegera Therapeutics has raised $21 million in the first close of its third round of financing. The round includes $14 million in venture equity and $7 million in venture debt. Report
> Metrics: There have been $16.6 billion worth of mergers and acquisitions in biotech since July, compared to $2.6 billion in the first half of the year. Report
> The UK's Acambis might be one of the next takeover targets, analysts say, after the biotech company missed out on a big U.S. vaccine contract. Report
> UN Secretary General Kofi Annan is raising new warnings about the spread of biological weapons. Report
> Mountain View, CA-based VIVUS is raising $33.6 million through the sale of common stock. Release
> Dyadic has raised $12.3 million through a private placement. Report
> Chutes & Ladders: Lawrence C. Fritz has been named president and CEO of Anadys Pharmaceuticals. Fritz had been CEO of Conforma Therapeutics. Report
And Finally... Australia's chief medical officer says containment efforts may have successfully averted the threat of a bird flu pandemic. Article